MedTrace Logo

German Inclisiran Network: Retrospective Registry of Patients Being Treated With the siRNA Inclisiran in Germany

NCT05438069 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2022-07-07

No results posted yet for this study

Summary

The German Inclisiran Network is a registry of patients with hypercholesterinemia on treatment with the siRNA inclisiran in Germany

Conditions

Sponsors & Collaborators

  • Universitätsklinikum Leipzig

    collaborator OTHER

  • Charite University, Berlin, Germany

    collaborator OTHER

  • Technische Universität Dresden

    collaborator OTHER

  • Deutsches Herzzentrum Muenchen

    collaborator OTHER

  • University of Rostock

    collaborator OTHER

  • Ruhr University of Bochum

    collaborator OTHER

  • Universitätsmedizin Mannheim

    collaborator OTHER

  • LMU Klinikum

    collaborator OTHER

  • Jena University Hospital

    lead OTHER

Principal Investigators

  • Oliver Weingaertner, MD · Jena University Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-11
Primary Completion
2025-12-11
Completion
2025-12-11

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05438069 on ClinicalTrials.gov